公众号 / 文章胸部技术与安全CT

肺癌筛查中偶发发现的有效管理:筛查审查会议的作用

Effective management of incidental findings in lung cancer screening: the role of the screening review meeting.
PubMed 文献 · Clin Radiol · 2025-08-21

约8%的受检者报告偶发发现(IFs)可能需要进一步处理,筛查审查会议(SRM)对这类患者的管理至关重要;NHS England标准方案要求设立此类多学科团队会议(MDT),但全国实施方式存在差异。本文详细介绍SRM的建立策略(资源、人员、组织与沟通),并总结近期IF管理证据与相关指南。

要点

  • 约8%的TLHC受检者在LDCT中报告偶发发现,可能需要进一步处理或检查。
  • NHS England的TLHC项目标准方案要求设立SRM这一MDT,但全国实施方式存在差异。
  • 本文提供SRM建立策略(资源、人员、组织与沟通),并总结IF管理近期证据与相关指南。

核心结论

  • SRM是管理LDCT偶发发现需升级处理患者的关键环节,NHS England标准方案要求设立该MDT,但全国实施方式存在差异;本文详述SRM建立策略并总结IF管理近期证据与相关指南。

诊断标准与关键数值

  • 目前TLHC中接受LDCT者约8%报告偶发发现,可能需要进一步处理或检查。

临床应用与阅片要点

  • NHS England的TLHC项目标准方案要求设立SRM这一MDT以管理偶发发现。
  • 本文详述SRM建立所需资源、人员、组织与沟通策略,供各中心参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Screening for lung cancer has been recommended in the UK by the United Kingdom national screening committee, who have suggested that all 4 UK nations move towards the implementation of targeted lung cancer screening (LCS). This is currently being rolled out in England through expansion of the successful targeted lung health check (TLHC) programme, with over half a million people having received a baseline low-dose computed tomography (LDCT) scan up to the end of January 2025. The screening review meeting (SRM) is essential for the management of patients who are escalated for further management of incidental findings (IFs) identified on their computed tomography (CT) scans. Currently, around 8% of those receiving an LDCT within the TLHC have an IF reported, which may require further action or investigation. Access to such a multidisciplinary team meeting (MDT) is mandated within the standard protocol from national health service (NHS) England for the TLHC Programme, but there is national variation in how this meeting is conducted. This article details strategies for setting up an SRM, including the required resources, personnel, organisation, and communication arising from this. Recent evidence for IF-related management is also summarised, with examples, as well as reference to relevant recent guidance.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Au-Yong ITH, Baldwin DR, George B, et al. Effective management of incidental findings in lung cancer screening: the role of the screening review meeting. Clin Radiol. 2025. PMID: 41014760. doi:10.1016/j.crad.2025.107055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。